How cheap are Canada's drugs really?

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 7, Issue 2, 2004, Pages 215-216

  Hollis, Aidan ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMLODIPINE BESYLATE; ATORVASTATIN; AZITHROMYCIN; CELECOXIB; CITALOPRAM; CLARITHROMYCIN; DIGOXIN; LANSOPRAZOLE; OLANZAPINE; PANTOPRAZOLE; RAMIPRIL; RISPERIDONE; ROFECOXIB; SIMVASTATIN; VENLAFAXINE;

ARTICLE; CANADA; CONTROLLED STUDY; DRUG COST; GOVERNMENT; HEALTH ECONOMICS; HEALTH INSURANCE; PHARMACY; PRESCRIPTION; UNITED STATES;

CANADA; COSTS AND COST ANALYSIS; ONTARIO; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES GOVERNMENT AGENCIES;

EID: 16544375002     PISSN: 14821826     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Commission on the Future of Health Care in Canada, Building on Values: The Future of Health Care in Canada - Final Report (Romanow Report). Ottawa, 2002.
2. Danzon, P., Making sense of drug prices. Regulation 23(1): 56-63, 2000.